Clinical Trial Update: Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Radium Ra-223 with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer; completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Radium Ra-223 (radium-223 dichloride)

Snippet

Sponsor: University of Utah | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-05-21